Toggle navigation
Home
Search
Services
Blog
Contact
About
Transdermal, Non-Invasive Monitoring of Medication Ingestion-281033009
Sequella, Inc., Rockville, MD, United States
Search grants from Sequella, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
GABABeta Regulation of METH-Induced Associative Learning
Diet, DNA Repair Genes and Breast Cancer Risk
Specialized Cancer Center Support Grant (CCSG)
Training Cardiovascular Biology: PREDOCTORAL
Sodium/Hydrogen Ion Transport in Renal Apical Membranes
Recently added grants:
Antigen recognition and activation of B-cell receptors of HIV-1 broadly neutralizing antibodies
Pathogenicity of amyloid containing biofilms
Multivalent Adjuvant Immunization to Prevent Hospital Acquired Infections
Registry Linkage to Improve Mortality Ascertainment and Assessment of Engagement in Care in Brazil, Mexico, and Peru
The Toxoplasma basal complex in cell division
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Small Business Innovation Research – Phase II (N44)
Project #
N44AA033009-001
Application #
6828889
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Sequella, Inc.
Department
Type
DUNS #
125129606
City
Rockville
State
MD
Country
United States
Zip Code
20850
Related projects
NIH 2004
N44 AA
Transdermal. Non-Invasive Monitoring of Medication Ingestion-281033009
/ Sequella, Inc.
NIH 2003
N44 AA
Transdermal, Non-Invasive Monitoring of Medication Ingestion-281033009
/ Sequella, Inc.
Comments
Be the first to comment on this grant